MIQLANJO Trademark

Trademark Overview

On Thursday, September 8, 2016, a trademark application was filed for MIQLANJO with the United States Patent and Trademark Office. The USPTO has given the MIQLANJO trademark a serial number of 87164842. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 27, 2020. This trademark is owned by Bristol-Myers Squibb Company. The MIQLANJO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
miqlanjo

General Information

Serial Number87164842
Word MarkMIQLANJO
Filing DateThursday, September 8, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 27, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 25, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 13, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, July 27, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 27, 2020ABANDONMENT - NO USE STATEMENT FILED
Wednesday, January 1, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 31, 2019EXTENSION 5 GRANTED
Thursday, December 19, 2019EXTENSION 5 FILED
Tuesday, December 31, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 19, 2019TEAS EXTENSION RECEIVED
Friday, June 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 19, 2019EXTENSION 4 GRANTED
Wednesday, June 19, 2019EXTENSION 4 FILED
Wednesday, June 19, 2019TEAS EXTENSION RECEIVED
Friday, December 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 19, 2018EXTENSION 3 GRANTED
Wednesday, December 19, 2018EXTENSION 3 FILED
Wednesday, December 19, 2018TEAS EXTENSION RECEIVED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, June 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 20, 2018EXTENSION 2 GRANTED
Wednesday, June 20, 2018EXTENSION 2 FILED
Wednesday, June 20, 2018TEAS EXTENSION RECEIVED
Thursday, December 21, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 19, 2017EXTENSION 1 GRANTED
Tuesday, December 19, 2017EXTENSION 1 FILED
Tuesday, December 19, 2017TEAS EXTENSION RECEIVED
Wednesday, June 21, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 25, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 25, 2017PUBLISHED FOR OPPOSITION
Wednesday, April 5, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 13, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 11, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 10, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 10, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 12, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 12, 2016NON-FINAL ACTION E-MAILED
Monday, December 12, 2016NON-FINAL ACTION WRITTEN
Monday, December 12, 2016ASSIGNED TO EXAMINER
Tuesday, September 13, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, September 12, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

miqlanjo diseases pharmaceutical human anti preparations disorders organ solid auto immune